Compare Amphastar Pharmaceuticals Inc (AMPH) vs Axogen Inc (AXGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Axogen Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Axogen Inc trades at $48.21 (market cap $2.61B). The key difference: Axogen Inc is far larger — about 3× Amphastar Pharmaceuticals Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | AXGN | |
|---|---|---|
Market Cap | $868.62M | $2.61B |
Sector | Health | Technology |
52-Week High | $30.81 | $48.48 |
52-Week Low | $16.87 | $14.16 |
Enterprise Value | $1.27B | $2.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →
